Dr. Vishnu N. Badavath, M.S., PhD, Post-doc.

Dr. Vishnu N. Badavath, M.S., PhD, Post-doc.

Hebrew University of Jerusalem

H-index: 19

Asia-Israel

About Dr. Vishnu N. Badavath, M.S., PhD, Post-doc.

Dr. Vishnu N. Badavath, M.S., PhD, Post-doc., With an exceptional h-index of 19 and a recent h-index of 17 (since 2020), a distinguished researcher at Hebrew University of Jerusalem, specializes in the field of CNS, Anti-cancer, Anti-bacterial, Anti-viral drugs.

His recent articles reflect a diverse array of research interests and contributions to the field:

Exploring indoor and outdoor dust as a potential tool for detection and monitoring of COVID-19 transmission

Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial

Recent insights into synthesis, biological activities, structure activity relationship and molecular interactions of thiazolidinone hybrids: A systematic review

Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiella pneumoniae infections

In Silico Docking Studies of Yucca gloriosa L. Phytoconstituents with TNF-α, IL-6 and IL-13 Receptor Against Asthma

Importance of In silico Tools in Anticancer Drug Discovery from Nature

Drug Repurposing and Computational Drug Discovery for Viral Infections and Corona Virus Disease 2019 (COVID-19)

Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection

Dr. Vishnu N. Badavath, M.S., PhD, Post-doc. Information

University

Position

Postdoctoral Scientist The Israel.

Citations(all)

990

Citations(since 2020)

825

Cited By

352

hIndex(all)

19

hIndex(since 2020)

17

i10Index(all)

30

i10Index(since 2020)

29

Email

University Profile Page

Hebrew University of Jerusalem

Google Scholar

View Google Scholar Profile

Dr. Vishnu N. Badavath, M.S., PhD, Post-doc. Skills & Research Interests

CNS

Anti-cancer

Anti-bacterial

Anti-viral drugs

Top articles of Dr. Vishnu N. Badavath, M.S., PhD, Post-doc.

Title

Journal

Author(s)

Publication Date

Exploring indoor and outdoor dust as a potential tool for detection and monitoring of COVID-19 transmission

Iscience

Suparinthon Anupong

Sudarat Chadsuthi

Parichart Hongsing

Cameron Hurst

Phatthranit Phattharapornjaroen

...

2024/3/15

Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial

EClinicalMedicine

Dhammika Leshan Wannigama

Cameron Hurst

Phatthranit Phattharapornjaroen

Parichart Hongsing

Natchalaikorn Sirichumroonwit

...

2024/4/1

Recent insights into synthesis, biological activities, structure activity relationship and molecular interactions of thiazolidinone hybrids: A systematic review

Sabnam Parveen

Ritchu Babbar

Vishnu Nayak Badavath

Suman Kumar Nath

Sourabh Kumar

...

2024/1/2

Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiella pneumoniae infections

Iscience

Dhammika Leshan Wannigama

Aye Mya Sithu Shein

Cameron Hurst

Peter N Monk

Parichart Hongsing

...

2023/7/21

In Silico Docking Studies of Yucca gloriosa L. Phytoconstituents with TNF-α, IL-6 and IL-13 Receptor Against Asthma

Chemical Biology Letters

Saurabh Gupta

Ajmer Singh Grewal

Geeta Deswal

Sachin Singh

Sukrati Vishwas

...

2023

Importance of In silico Tools in Anticancer Drug Discovery from Nature

Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach

Gnana Ruba Priya Muthaiah

Motamarri Venkata Naga Lalitha

Seema Sajjan Singh Rathore Chaitanya

Maida Engels SE

Vishnu Nayak Badavath

2023/11/2

Drug Repurposing and Computational Drug Discovery for Viral Infections and Corona Virus Disease 2019 (COVID-19)

James H Zothantluanga

Arpita Paul

Abd Kakhar Umar

Dipak Chetia

2023/10/27

Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection

Biomedicine & Pharmacotherapy

Aye Mya Sithu Shein

Dhammika Leshan Wannigama

Cameron Hurst

Peter N Monk

Mohan Amarasiri

...

2023/12/1

Anti-Amyloid-β Immunotherapy: A Leading Novel Avenue for Alzheimer's Disease

Parth Sharma

Ritchu Babbar

Twinkle Sharma

Piyush Madaan

Sandeep Arora

...

2023

Crystal growth, optoelectronic and biological properties of acetamidinium compounds: experimental and computational approaches

Journal of Materials Science: Materials in Electronics

C Sudhakar

Saravanabhavan Munusamy

Ramesh Shanmugam

Shabbir Muhammad

Saifeldin M Siddeeg

...

2023/1

Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer’s disease

Metabolic Brain Disease

Dapinder Kaur

Tapan Behl

Aayush Sehgal

Sukhbir Singh

Neelam Sharma

...

2022

Pharmacological and Quantum Chemical Studies of 2-aminobenzo [d] thiazol-3-ium 4-chlorobenzenesulphonate: Synthesis, Spectral, Thermal Analysis and Structural Elucidation

Results in Chemistry

C Sudhakar

M Saravanabhavan

KS Ramesh

VN Badavath

S Chandrasekar

...

2022

Discovery of 3-chlorobenzyl-linked 1, 9-diazaspiro [5.5] undecane derivatives, a lead for dengue virus type 2 infection

New journal of chemistry

Madhu Sudhana Reddy Gangireddy

Vishnu Nayak Badavath

Caroline Velez

Naphat Loeanurit

Abhishek Thakur

...

2022

High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be …

Scientific Reports

Aye Mya Sithu Shein

Dhammika Leshan Wannigama

Paul G Higgins

Cameron Hurst

Shuichi Abe

...

2022/7/28

Brain permeable curcumin-based pyrazoline analogs: MAO inhibitory and antioxidant activity

Journal of Molecular Structure

Vishnu Nayak Badavath

Abhishek Thakur

Deepak Shilkar

Chandrani Nath

Orlando Acevedo

...

2022/11/15

Novel imidazo [1, 2-a] pyridine derivatives induce apoptosis and cell cycle arrest in non-small cell lung cancer by activating NADPH oxidase mediated oxidative stress

Life Sciences

Pal Durba Bhavya Kumari

Mantipally Manohar

Roy Soumyajit

Arora Leen

Badavath Vishnu Nayak

...

2022

Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin–sulbactam …

Scientific reports

Sukrit Srisakul

Dhammika Leshan Wannigama

Paul G Higgins

Cameron Hurst

Shuichi Abe

...

2022/7/6

Pharmacophore modeling in drug design

Siddhartha Maji

Subrat Kumar Pattanayak

Anik Sen

Vishnu Nayak Badavath

2022/1/1

Primer for designing main protease (Mpro) inhibitors of SARS-CoV-2

The journal of physical chemistry letters

Acevedo Orlando Thakur Abhishek

Sharma Gaurav

Badavath Vishnu Nayak

Jayaprakash Venkatesan

Merz Jr Kenneth

...

2022

Exploring the role of ubiquitin–proteasome system in Parkinson's disease

Tapan Behl

Sachin Kumar

Ziyad M Althafar

Aayush Sehgal

Sukhbir Singh

...

2022/7

See List of Professors in Dr. Vishnu N. Badavath, M.S., PhD, Post-doc. University(Hebrew University of Jerusalem)

Co-Authors

H-index: 51
SIMONA BUNGAU

SIMONA BUNGAU

Universitatea din Oradea

H-index: 36
Galia Blum

Galia Blum

Hebrew University of Jerusalem

H-index: 36
Dr. Saurabh Bhatia

Dr. Saurabh Bhatia

Amity University

H-index: 32
Venkatesan Jayaprakash

Venkatesan Jayaprakash

Birla Institute of Technology

H-index: 31
Orlando Acevedo

Orlando Acevedo

University of Miami

H-index: 29
Prof. B.N. Sinha

Prof. B.N. Sinha

Birla Institute of Technology

academic-engine